Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
25-Hydroxycholesterol Drives Immunosuppressive TAM Metabolis
2026-05-26
Xiao et al. reveal that 25-hydroxycholesterol (25HC) accumulation in tumor-associated macrophages (TAMs) drives immunosuppression by activating lysosomal AMPKα and inducing a metabolic shift that sustains STAT6-ARG1 signaling. This mechanistic insight informs immunometabolic intervention strategies and highlights CH25H as a checkpoint for anti-tumor immunity.
-
KX2-391 Dihydrochloride: Dual-Action Assays in Oncology and
2026-05-25
KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) stands apart as a dual mechanism Src kinase and tubulin polymerization inhibitor with validated activity in cancer, viral, and neurotoxin research. This guide delivers applied protocols, optimization strategies, and troubleshooting tips to maximize reproducibility and data quality across these domains.
-
Eliminating Pollen Interference in Fluorescence Bioaerosol D
2026-05-25
The reference study demonstrates a machine learning-driven strategy to overcome pollen spectral interference during hazardous bioaerosol classification using excitation–emission matrix fluorescence spectroscopy. This work substantially improves the accuracy of detecting pathogenic bacteria and toxins in complex airborne mixtures, providing a methodological advance for environmental and public health monitoring.
-
Evaluating Fumagillin for Control of Azumiobodo hoyamushi in
2026-05-24
This study systematically investigated twenty antiprotozoal agents—including Fumagillin—for their efficacy against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in edible ascidians. The findings provide evidence-based guidance for selecting candidate drugs in aquaculture disease management and highlight the translational relevance of methionine aminopeptidase-2 inhibitors.
-
Cell lysis buffer for WB and IP: Powering Robust Protein Ext
2026-05-23
Unlock high-yield, non-denaturing protein extraction from challenging samples—animal, plant, or microbial—with Cell lysis buffer for WB and IP. Learn how optimized inhibitor cocktails and workflow tuning boost Western blot and immunoprecipitation sensitivity, especially in complex tumor microenvironment studies.
-
PF-562271 HCl: Advanced FAK/Pyk2 Inhibitor Workflows in Canc
2026-05-22
PF-562271 HCl empowers researchers to dissect focal adhesion kinase signaling with precise, selective inhibition, offering robust tools for modeling tumor growth and metastasis. This guide translates bench-proven workflows and troubleshooting strategies into actionable, reproducible cancer research protocols.
-
Vasopressin Analogues: Expanding Therapeutic and Research Ho
2026-05-22
The reviewed article systematically examines vasopressin and its analogues, highlighting their evolution from natural hormones to multifunctional peptide therapeutics. Key advancements include the use of lypressin acetate in diabetes insipidus and emerging antiviral applications, offering researchers new avenues for disease modeling and mechanistic studies.
-
Trelagliptin Succinate Improves Insulin Resistance in Adipoc
2026-05-21
This study reveals that trelagliptin succinate, a DPP-4 inhibitor, enhances insulin signaling in adipocytes by upregulating the PI-3K/AKT/GLUT4 pathway. The findings clarify the mechanistic basis for its beneficial effects on glucose uptake and adipokine regulation, offering new insights into the molecular management of insulin resistance.
-
Dual Mechanism Src and Tubulin Inhibition by KX2-391: Insigh
2026-05-21
The reference study defines KX2-391 (Tirbanibulin dihydrochloride) as a first-in-class small molecule that uniquely inhibits Src kinase through a substrate-binding site and disrupts tubulin polymerization. This dual mechanism demonstrates high selectivity, potent cellular efficacy, and translational promise for oncology and antiviral research, while challenging traditional paradigms in protein kinase inhibitor design.
-
Open-Platform DLP Enables Precise 96-Well Hydrogel Printing
2026-05-20
The referenced study introduces a low-cost, open-platform digital light printer (OP-DLP) optimized for high-throughput hydrogel synthesis and spatial light-activation in 96-well formats. This innovation enables reproducible, customizable hydrogel fabrication and spatially precise biomolecule activation, supporting advanced cell and material studies.
-
Metoprolol in Translational Research: PK Variability and Adv
2026-05-20
Explore Metoprolol as a selective beta1-adrenoceptor antagonist in translational research, with a focus on pharmacokinetic variability and advanced assay design. This article uniquely integrates reference-based insights and protocol guidance for cardiovascular, anti-inflammatory, and cancer biology studies.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Practical Us
2026-05-19
The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) preserves protein phosphorylation during sample preparation by inhibiting a broad range of endogenous phosphatases. It is best used in workflows such as immunoblotting, kinase activity assays, and mass spectrometry where phosphorylation state integrity is essential. It is not suitable for diagnostic or medical applications.
-
Zosuquidar (LY335979): Transforming MDR Strategies in Oncolo
2026-05-19
This article provides a mechanistic and strategic deep dive into Zosuquidar (LY335979) 3HCl's role as a P-glycoprotein inhibitor, offering translational researchers actionable guidance for overcoming multidrug resistance in cancer. Integrating recent pharmacokinetic insights and clinical perspectives, it positions Zosuquidar as an indispensable tool for advancing both experimental and therapeutic innovation.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody: Mechanisms, Sensitiv
2026-05-18
Explore the molecular mechanisms and advanced assay design enabled by the Cy3 Goat Anti-Human IgG (H+L) Antibody. This in-depth analysis reveals unique strategies for maximizing sensitivity and specificity in immunofluorescence and related assays.
-
Amikacin Sulfate: Molecular Precision in Granulomatous Infec
2026-05-18
Explore the molecular pharmacology of Amikacin Sulfate in non-tuberculous mycobacterial research. This article delivers new insights into intracellular antibiotic kinetics and targeted delivery, offering practical guidance for advanced infection modeling.